Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Argenx Se ADR (ARGX)

Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,017,642
  • Shares Outstanding, K 59,302
  • Annual Sales, $ 1,269 M
  • Annual Income, $ -295,050 K
  • 60-Month Beta 0.65
  • Price/Sales 17.70
  • Price/Cash Flow N/A
  • Price/Book 5.47
Trade ARGX with:

Options Overview Details

View History
  • Implied Volatility 40.29% ( +4.69%)
  • Historical Volatility 32.15%
  • IV Percentile 51%
  • IV Rank 19.20%
  • IV High 108.65% on 07/14/23
  • IV Low 24.05% on 08/30/23
  • Put/Call Vol Ratio 0.32
  • Today's Volume 278
  • Volume Avg (30-Day) 196
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 5,272
  • Open Int (30-Day) 7,478

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.79
  • Number of Estimates 13
  • High Estimate -0.13
  • Low Estimate -1.39
  • Prior Year -0.52
  • Growth Rate Est. (year over year) -51.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
361.38 +0.04%
on 03/18/24
413.10 -12.48%
on 02/23/24
-30.69 (-7.82%)
since 02/16/24
3-Month
327.73 +10.32%
on 12/21/23
458.86 -21.21%
on 12/19/23
-93.94 (-20.62%)
since 12/18/23
52-Week
327.73 +10.32%
on 12/21/23
550.76 -34.36%
on 07/21/23
+1.87 (+0.52%)
since 03/17/23

Most Recent Stories

More News
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond

These five biotech companies could have a lot of room to run.

AMGN : 270.90 (+0.76%)
ARGX : 361.54 (-2.62%)
BGNE : 168.50 (-0.88%)
CRSP : 71.47 (-2.03%)
IMVT : 30.27 (-0.85%)
Carlyle Group, Seadrill rise; PG&E, Argenx fall, Tuesday, 11/28/2023

Stocks that traded heavily or had substantial price changes on Tuesday: Carlyle Group, Seadrill rise; PG&E, Argenx fall

SDRL : 49.61 (+1.47%)
TWLO : 60.71 (+1.76%)
ARGX : 361.54 (-2.62%)
WPC : 55.42 (-1.02%)
PCG : 16.06 (-1.17%)
These 2 Stocks Are Falling in a Fading Rally

It's been a good month, but the stock market's looking tired.

ZS : 195.94 (+0.98%)
ARGX : 361.54 (-2.62%)
Why Immunovant Stock Is Bolting Higher Today

The company may have best-in-class autoimmune disease therapy under its roof.

ARGX : 361.54 (-2.62%)
JNJ : 156.76 (-0.90%)
IMVT : 30.27 (-0.85%)
ROIV : 9.87 (-2.66%)
Argenx's 28% Surge & Promising Product Propel Investor Confidence

Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.

ARGX : 361.54 (-2.62%)
ABBV : 178.49 (+0.34%)
ABCL : 4.59 (-2.55%)
ALNY : 147.41 (-1.25%)
AMGN : 270.90 (+0.76%)
ANAB : 23.17 (-1.19%)
AZN : 65.85 (-0.69%)
BMY : 51.59 (-1.43%)
INCY : 57.34 (-1.76%)
REGN : 959.92 (-0.47%)
VIE : 53.01 (unch)
Is Argenx Stock a Buy Now?

Good news keeps rolling in for the biotech.

ARGX : 361.54 (-2.62%)
Why Shares of Argenx Jumped This Week

The company's lead therapy showed progress in treating an autoimmune disorder.

ARGX : 361.54 (-2.62%)
Why Argenx Stock Is on Fire Today

A major clinical win is boosting the drugmaker's shares today.

ARGX : 361.54 (-2.62%)
You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers

Big gains are afoot even as the markets prepare for a flat open.

COMP : 3.06 (+4.44%)
$NASX : 16,103.45 (+0.82%)
ARGX : 361.54 (-2.62%)
BBIO : 27.81 (+0.91%)
This Emerging Market Could Be the Next Big Thing in Biotech

Medicines to treat the many symptoms of long COVID are in high demand already.

PRTC : 25.85 (+1.06%)
PFE : 27.72 (-0.79%)
ARGX : 361.54 (-2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

See More

Key Turning Points

3rd Resistance Point 373.24
2nd Resistance Point 370.84
1st Resistance Point 366.19
Last Price 361.54
1st Support Level 359.14
2nd Support Level 356.73
3rd Support Level 352.08

See More

52-Week High 550.76
Fibonacci 61.8% 465.56
Fibonacci 50% 439.24
Fibonacci 38.2% 412.92
Last Price 361.54
52-Week Low 327.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar